A carregar...
Programmed death-ligand 1 (PD-L1) is expressed in a significant number of the uterine cervical carcinomas
BACKGROUND: The programmed death-1/programmed death-ligand-1 (PD-1/PD-L1) immune regulatory axis has emerged as a promising new target for cancer therapeutics, with lasting responses seen in the treatment of metastatic renal and lung carcinomas, as well as melanomas. As tumor surface expression of P...
Na minha lista:
| Publicado no: | Diagn Pathol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5473984/ https://ncbi.nlm.nih.gov/pubmed/28623908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-017-0631-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|